New TN Trial Tests Earlier Gamma Knife

A new trial is testing whether doctors should offer Gamma Knife radiosurgery earlier in trigeminal neuralgia treatment. That is the real development here. Gamma Knife is not new. What is new is the attempt to move it further forward in the treatment pathway, before some patients spend longer living with severe pain and rising medication burden.

What is changing in trigeminal neuralgia treatment

Researchers at the University of Alberta are running the URGEnt-TN study, a phase II randomised controlled trial of ultra-early Gamma Knife stereotactic radiosurgery in people with classical or idiopathic trigeminal neuralgia who are described as pre-refractory. In plain English, the team wants to know whether carefully selected patients may do better if doctors consider radiosurgery earlier, rather than waiting through a longer cycle of escalating drug treatment. PubMed: URGEnt-TN study protocol and ClinicalTrials.gov: NCT06949436.

The published protocol says the ultra-early Gamma Knife has not yet been examined in patients treated soon after TN diagnosis and before medical refractoriness. It states that participants in the trial will be treated before they develop a medically refractory state and within two years of being diagnosed with TN. The University of Alberta trial report explains the purpose of the study in more accessible terms.

Why earlier Gamma Knife matters

Current UK pathways still start with medication. The NHS trigeminal neuralgia treatment page says most people with trigeminal neuralgia are prescribed medicine to help control pain, and carbamazepine is currently the only medicine licensed to treat trigeminal neuralgia in the UK. The NHS also notes that carbamazepine can be very effective at first but may become less effective over time.

NICE guidance on stereotactic radiosurgery for trigeminal neuralgia recognises it as an established option for adults and describes it as focusing radiation on the trigeminal nerve to damage it, thereby relieving pain.

That matters because medication is not a neutral waiting room. For many patients, delay means more than time passing. It can mean side effects, uncertainty, disrupted sleep, difficulty eating or speaking, and a steady loss of ordinary life.

What the trial does and does not show

This is where caution matters. The published paper is a study protocol, not a results paper. The researchers are testing whether ultra-early Gamma Knife can improve long-term pain control compared with ongoing medical management. No one should present this as proof that earlier Gamma Knife should now become standard care. PubMed: URGEnt-TN study protocol.

But that does not weaken the story. It strengthens it, because the question itself is worth asking. If earlier Gamma Knife improves long-term pain control, it could alter the sequence of trigeminal neuralgia treatment. If it does not, that result still matters. It would help clarify where Gamma Knife belongs in the treatment pathway.

What this could mean for patients

At TNA UK, we know patients need more than treatment alone. They need access to the right treatment at the right time. That is why this study stands out. It moves the debate beyond a simple choice between medicines and procedures and focuses on something more practical: whether too many people endure prolonged pain before the system explores meaningful alternatives.

This is not a story about a new machine or a new procedure. It is a story about timing. Gamma Knife is not new. The real question is whether some TN patients should reach it sooner.

Frequently asked questions about Gamma Knife for TN

Is Gamma Knife an operation?

Gamma Knife is described as stereotactic radiosurgery, but it does not involve open surgery or a cut in the skin. The NHS says no cuts are made, and general anaesthetic is not required for stereotactic radiosurgery for trigeminal neuralgia. NHS trigeminal neuralgia treatment page.

How does Gamma Knife help trigeminal neuralgia?

The aim is to focus radiation on the trigeminal nerve where it enters the brainstem. NICE says the procedure focuses radiation on the trigeminal nerve to damage it and relieve pain. NICE guidance on stereotactic radiosurgery.

Is Gamma Knife the first treatment for TN?

Usually not. The NHS says most people with trigeminal neuralgia are first prescribed medicine to control pain, and surgery or procedures are considered later if medicine is ineffective or causes too many side effects. NHS trigeminal neuralgia treatment page.

What is new about this trial?

What is new is not Gamma Knife itself. The URGEnt-TN protocol is testing ultra-early Gamma Knife in selected pre-refractory patients with classical or idiopathic TN. The current publication is a study protocol, not a results paper. PubMed: URGEnt-TN study protocol.

Does this trial prove earlier Gamma Knife works better?

No. It sets out what researchers plan to test. It does not prove that earlier Gamma Knife should become standard treatment. PubMed: URGEnt-TN study protocol.

Does Gamma Knife work immediately?

Not always. The NHS says it can take a few weeks, or sometimes many months, to notice any change after stereotactic radiosurgery. NHS trigeminal neuralgia treatment page.

Are there risks or side effects?

Yes. The NHS says facial numbness and pins and needles in the face are the most common complications associated with stereotactic radiosurgery, and these side effects can be permanent. NHS trigeminal neuralgia treatment page.

Sources

• University of Alberta, Gamma Knife trial offers hope to people with trigeminal neuralgia.

• PubMed, Ultra-early Gamma Knife stereotactic radiosurgery for trigeminal neuralgia (URGEnt-TN).

• ClinicalTrials.gov, NCT06949436.

• NHS, Trigeminal neuralgia treatment.

• NICE, Stereotactic radiosurgery for trigeminal neuralgia.

Aneeta Prem is CEO of TNA UK and a national campaigner for people living with trigeminal neuralgia and facial pain.